ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201241 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201241; 2) Community: the network communities that were significantly associated with the response to NSC 201241; 3) Molecule: the relationships between components within communities and NSC 201241; 4) MDR: the compounds that were significantly associated with the NSC 201241.

NSC Compound Enrichment Correlation
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0395466756030202 0.016402237
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0395466756030202 -0.085039598
NSC 328784 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide 0.0395466756030202 -0.014620257
NSC 359239 Antibiotic X-14766A 0.0395466756030202 0.33260128
NSC 409749 Null 0.0395466756030202 0.026618987
NSC 619030 Analog of CC-1065 0.0395466756030202 0.17474663
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.0395466756030202 -0.05559582
NSC 647763 Jasplakinolide epoxide C 0.0395466756030202 0.13886388
NSC 677784 Null 0.0395466756030202 -0.15127276
NSC 681633 Camptothecin Derivative 0.0395466756030202 -0.11067322
Total:12  Current:9    [First] [Prev] [Next] [Last]